lipid disorders ms2 cardiovascular lecture #62 november 7, 2006 richard j. baltaro, m.d., ph.d.,...

79
Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton University Medical Center 601 N. 30th Street Omaha, NE 68131-2197 USA [email protected]

Upload: blanche-morgan

Post on 25-Dec-2015

217 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton

Lipid Disorders MS2 Cardiovascular Lecture #62

November 7, 2006

Richard J. Baltaro, M.D., Ph.D., FCAP

Associate Professor

Department of Pathology

Creighton University Medical Center

601 N. 30th Street

Omaha, NE 68131-2197 USA

[email protected]

Page 2: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton

Reading Material

• Robbins and Cotran Pathologic Basis of Disease, Seventh Edition, Elsevier Saunders, 2003 Vinay Kumar, MBBS, MD, FRCPath, Univ. of Chicago, Abdul Abbas, MBBS, Univ of Ca, SF & Nelson Fausto, MD Univ. Washington

pp. 156-158 Chapter 5, Disorders Associated with Defects in Receptor Proteins, Familiar Hypercholesterolemia pp. 520-523, 525f Chapter 11, Hyperlipidemia & Atherosclerosis

• CECIL Essentials of Medicine, 6th Edition, W.B. Saunders Co, 2004

pp. 563-570, Chapter 61, Disorders of Lipid Metabolism, Reed E. Pyeritz. M.D., Ph.D., Univ. of Pa

Page 3: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton

QuickTime™ and aTIFF (Uncompressed) decompressor

are needed to see this picture.

Women brave tribal elders, warlords to vote Kabul, Afghanistan September 20, 2005

Making history … a woman gestures while talking to voters in Kabul. Some women were forced to hand over their voting cards so others would vote for them.

Page 4: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton

The Lipid Fairy Tale: IN THE BEGINNING … a long time ago in1948, in a place near

• FAT WAS GOOD !

• SATURATED FATS WERE GOOD !

• Cigarettes were recommended by doctors !

• High blood pressure happened !

• Thin was bad … possible sign of TB, pneumonia, infectious disease, infant or maternal mortality, malnutrition, etc.

Page 5: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton
Page 6: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton
Page 7: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton
Page 8: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton

Heart Attack Epidemic Begins in USA 1930-1948 …

• From 1900 to 1963 Cardiovascular and Renal mortality increased 53%

• Infectious diseases decreased

• After World war II there was a need to understand the pathogenesis of heart attacks.

Page 9: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton

1948 … Prospective Studies Begin after World War II

• 1) NIH funds Framingham study (Prospective Epidemiological Study of Healthy and Free of Disease)

• 2) Johns Hopkins University, Baltimore, MD starts following prospectively their medical school graduates

• 3) Richard Doll & Richard Peto study the British Physicians lifestyle and survival

Page 10: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton
Page 11: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton

Framingham, Massachusetts

• About 18 miles west of Boston, 20K people• The study would follow a group of normal

people for a period of years to see who among them got high blood pressure, heart attacks and stroke.

• The town’s doctors were cooperative• 5000 residents between 30 and 59 years

participated with regular check-ups 1950-74

Page 12: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton

Fatty streaks … 1950

• Pathologists describe fatty streaks in the aortas young men killed in action during the Korean War (1950-1951) see Robbins Fig. 12-9 page 502

• Cigarettes and Good Hearty American High Animal Fat Content Food is given freely to soldiers to improve morale and maintain health

• High blood pressure not usually treated• Health “nuts” (non-physician groups) raise issues

about safety of too much cholesterol in diet

Page 13: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton
Page 14: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton

Late September 1955…The President recovering from MI

• On the Friday following the unfortunate heart attack, President Dwight D. Eisenhower, recovered in the Denver military hospital, “he asked and got, a stump of his favorite beef bacon.” The next breakfast he had soft boiled eggs, prunes, oatmeal, toast and milk. Later he had servings of steak, prime ribs of beef and so forth.

• In the 1950s smoking was considered of such unimportance in heart disease that Ike’s long smoking history was not even mentioned.

Page 15: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton
Page 16: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton

Progress? 1955 -1992

Page 17: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton

NIH 1967

• Donald Fredrickson and his people in the NIH’s molecular diseases branch of the heart institute publish .

• Fredrickson et al., “ Fat Transport in Lipoproteins -- an integrated Approach to Mechanisms and Disorders,” NEJM 276 (January 5, 1967):34-42 and the four following issues

Page 18: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton

From Cecil Essentials of Medicine, 2001

Note: Updated table 6-1 in 7th edition essentially unchanged

Page 19: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton
Page 20: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton
Page 21: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton

Lipoprotein (An Artist’s view)

Page 22: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton

Fredrickson’s Formula

• LDL = TC - (TG/5 + HDL)• Memorize, still used today• TC= Total Cholesterol• TG = Triglycerides (divide by 5)• HDL = HDL Cholesterol• LDL is still calculated this way• LDL calculated vs.. LDL measured (direct)• LDL calculated may be significantly off in 10%

Page 23: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton
Page 24: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton

Fredrickson’s Classification of

Hyperlipoproteinemias - Robbins page 508

Page 25: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton

Type I

• Hyper TG• Chylomicrons• Serum milky• High cholesterol• High TG• < 1%• No Atherosclerosis • Rx:Diet, No alcohol

Page 26: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton

Type II

• High cholesterol• Clear serum• Xanthelasma• Corneal Arcus• Atheroscler. +++• 4 genetic

Conditions

Autosomal Dominant

Page 27: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton

Type II

• Tendon &

Tuberous Xanthomas

• 10% IIA

Only cholesterol

• 40% IIB (!!!)

Both chol & TG

• Rx Diet, drugs

Page 28: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton

A 40 year-old man to the ER for evaluation of chest pain AND severe “heartburn”. The Achilles tendons bilaterally have painless, fleshy, faintly yellow lesions:

DIAGNOSIS?

Page 29: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton

Primary vs. Secondary Hypercholesterolemias

Cholesterol elevated in:• Cholestasis, intra- or extra-hepatic• Nephrotic Syndrome• Hypothyroidism• Oral Contraceptives• Normal Pregnancy• Acute Intermittent Porphyria (AIP)• Macroglobulememia … & other conditions

Page 30: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton

Type III

• Rare electrophoretic pattern of abnormal LP

• Atherosclerosis +++ (atherogenic)

• Remnant chylomicrons & IDL Intermediate

• Mutation in apolipoprotein E

• TG & cholesterol both greatly elevated

• Uncommon not rare < 1 % of primary LP

• Rx : Diet & reduction in weight

Page 31: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton

Type IV (2 different genetic)

• Increase in VLDL & TG• Possibly atherogenic• Common: 45% of cases (Rx diet & drugs)• Example: mutation in LP lipase gene• Secondary hypertriglyceridemias in:Non-fasting specimen (most common)Diabetes, Acute alcoholism,Oral contraceptives,

Nephrotic syndrome, CRF, Steroids, Acute pancreatitis, Gout, Gram negative infections,etc.

Page 32: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton

TypeV

• Pancreatitis• Eruptive

Xanthomas• Adults• ? atherosclerosis• 5% of total• DM,Alcohol• Rx Diet,drugs

Page 33: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton

Hypolipidemia

• Hypolipidemia (Hypoproteinemia) - rare familial disorders or secondary to hyperthyroidism, malabsorption, malnutrition e.g. AIDS, cancers

• Hypo-alphalipoprotenemia (Low HDL) associated with increased CAD: genetic or secondary to obesity, sedentary, cigarettes, diabetes, nephrotic syndr., medications (beta-blockers, diuretics, steroids, progestationals,..) lack of red wine…In about 10 % of population - important

Page 34: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton

Hypolipidemias (continued)

• Hypo-beta-lipoproteinemia, rare inherited reduced LDL gene mutation of apo B

• Total cholesterol 70-120 mg/dl• Decreased CAD & so called together with familial

hyper-alpha lipoprotenemia … “longevity syndr”• Familial alpha-Lipoprotein Deficiency or

Tangier’s disease (see next slide)• A-beta-lipoproteinemia or Bassen-Kornzweig

Syndrome (see slide after that)

Page 35: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton

Familial alpha-Lipoprotein Deficiency Tangier’s disease

Rare familial, genetics ?

Plasma cholesterol very low

Marked decreased HDL

Triglycerides normal

Polyneuropathy,

lymphadenopathy

Orange-yellow tonsils

Page 36: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton

A-beta-lipoproteinemiaBassen-Kornzweig Syndr.

• Robbins p. 815 • Rare congenital • Autosomal Recessive• Defect in intestine• No LDL, VLDL, & Chylomicrons• Low Cholesterol & TG• Burr cells (acanthocytes)• Failure to thrive• Diarrhea, steatorrhea

Page 37: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton

Lipidoses (Lipid Storage Diseases) Not covered here

• Gaucher’s disease (glucocerebroside lipidosis)• Niemann-Pick disease• Fabry’s disease (alpha-galactosidase A deficiency)• Wolman disease (acid cholesteryl ester hydrolase deficiency)

• Cholesteryl Ester Storage disease• Cerebrotendinous Xanthomatosis • Beta-Sitosterolemia & Xanthomatosis• Refsum’s disease (phytanic acid storage disease)• Tay-Sachs disease (GM2 gangliosidosis)

• Etc., etc.

Page 38: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton

Bad news from Framingham, MA

• Organizers are overwhelmed at how many of the Framingham’s adults free of disease in 1950 developed heart disease as time went on.

• Fully 1/3 of the men who had been in their early 40s when the study begun had signs of heart disease by 1974

• 2/3 of the healthy 50-59 year old at the beginning of the study had heart disease by 1974 (1948-1974)

Page 39: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton
Page 40: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton

Framingham “Final” Results 1974

• LIPIDS ARE BAD, especially if your cholesterol is abnormally high (Normal in 1960-1970s up to 300 mg/dl)

• Risk factors: SMOKINGHIGH CHOLESTEROL

HIGH BLOOD PRESSURE

DIABETES

Page 41: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton
Page 42: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton

FraminghamBottom Line

• Four Potentially

Controllable:

• SMOKING

• CHOLESTEROL

• Systemic HBP

• DIABETES

Page 43: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton
Page 44: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton

Same asFig 11-10 p. 520 7th edRobbins

Page 45: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton

2004 JAMA

• Cholesterol, Smoking, Hypertension and Diabetes Account for about 80% of the Predictive value!

• (Clinical pearl aka My editorial comment: Concentrate on these & …

• Downplay the other thousands of Risk Factors!)

Page 46: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton
Page 47: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton

Serum Homocysteine

Page 48: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton

Hs-CRP = “high sensitivity” C- Reactive Protein

Page 49: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton

Familial Hypercholesterolemia

• Robbins, 7th ed, see pages 156-158• Is a “receptor disease”• Mutation in the gene encoding for the receptor for

Low Density Lipoprotein (LDL), which is involved in the transport & metabolism of cholesterol

• 1/500 individuals heterozygous, possibly the most frequent mendelian disorder

• Tendinous xanthomas & premature atherosclerosis

Page 50: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton

Low ("Lousy") Density Lipoprotein (LDL-C)

• This "BAD" cholesterol is carried into the blood and is the main cause of harmful fatty buildup in the arteries.

• LDL-C is mostly fat with a small amount of protein.• The higher the LDL-C level in the blood, the greater the

risk of heart disease. • LDL-C is strongly influenced by genetic factors. One of

the other important causes of elevated LDL-C levels is a diet high in saturated fats (fats found in animal products), trans fatty acids (hydrogenated fats) and cholesterol (found only in animal products).

Page 51: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton

High ("Healthy") Density Lipoprotein (HDL-C) = The “Good” Cholesterol

It prevents cholesterol from building up in the arteries. It is mostly protein and contains only a small amount of fat. HDL-C clears the bad cholesterol from the body by picking up cholesterol from the walls of the arteries and carrying it back to the liver for disposal.

Exercise increases the production of HDL-C. A higher HDL-C is linked with a lower risk of heart disease, stroke and atherosclerosis. Exercise can also help control weight, diabetes and high blood pressure. Exercise that uses oxygen to provide energy to large muscles (aerobic exercise) raises your heart and breathing rates. Stopping smoking will also improve HDL-C levels.

Estrogen and moderate alcohol intake can also raise HDL-C. Women have higher levels of HDL-C as compared to men. Women are just as likely as men to die for heart disease but the onset tends to be later in life.

Page 52: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton

Chapter 5GeneticDisordersp. 157Robbbins7th ed.

Page 53: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton

LDL Receptor Pathway Fig 5-9. P. 158, Robbins 7th ed

Page 54: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton

As previously discussed!

• About 2 in 3 has a total cholesterol < 240 mg/dl

• About 2 in 3 is a non smoker

• About 2 in 3 has a normal diastolic blood Pressure

• Over 90% is a non diabetic

Page 55: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton

1988 NIH Consensus NCEP

• Expert Panel of the National Education Cholesterol Program, Arch Inter Med 1988; 148: 36-69. Establishes for Adults:

• < 200 mg / dl is desirable for TC cholesterol

• 200 - 239 mg /dl is borderline

• Over 240 mg / dl is HIGH

• Either a fasting or non fasting specimen OK

Page 56: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton
Page 57: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton

NIH 3rd Report of NCEP May 2001

Page 58: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton

J curve Controversy Total vs. CV mortality - Cholesterol & BP

• Cardiovascular Mortality increases directly with Total cholesterol values (or Systemic blood pressure) in the population

• Mortality from all causes is about steady from 150-240 cholesterol

• Mortality from all causes actually increases with low cholesterol and blood pressure

Page 59: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton

J curve Controversy Total vs. CV mortality - Alcohol consumption

QuickTime™ and aTIFF (Uncompressed) decompressor

are needed to see this picture.

Page 60: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton
Page 61: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton

Some of the Major Antioxidant and Phenolics in Wines

Page 62: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton

Antioxidant Capacities and Phenolics Levels of French Wines from Different Varieties and Vintages,

Landrault, N, et al, J. Agric. Food Chem. 49, 3341-3348, 2001.

Page 63: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton

Prevalence distribution (bars) of serum cholesterol concentration related to age-adjusted mortality from coronary heart disease (CHD) (broken curve) in men aged 40-59 years. The number above each bar is the percentage of death "attributable" to the cholesterol effect and arising at that level. Data from Martin et al [96].

Page 64: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton

CIS- OILS

CIS

“ONLY”

IS

NATURAL

NOT

TRANS

Page 65: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton

QuickTime™ and aTIFF (Uncompressed) decompressor

are needed to see this picture.

Page 66: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton
Page 67: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton

QuickTime™ and aTIFF (Uncompressed) decompressor

are needed to see this picture.

QuickTime™ and aTIFF (Uncompressed) decompressor

are needed to see this picture.

Here are some examples:French fries (fast food)7.8gDoughnut5.0gMicrowave popcorn4.5gPound cake4.3gShortening4.2gWheat crackers4.0gPotato chips3.2gStick margarine2.8gTub margarine0.6g

Page 68: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton

2005 Genetics …

• About 15% of people have ApoE-4, which has been linked to heart disease, stroke and Alzheimer’s disease. (“Unlucky gene”)

• About 8% of population have ApoE-2, “the lucky gene”, which is associated with longer life and a lower risk of degenerative diseases.

• Most people carry ApoE-3, which does not affect health risks.

• Testing people for ApoE genes as a clinical tool is NOT recommended except to further investigate an independent Alzheimer’s diagnosis.

Page 69: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton

2004 Genetics from CECIL p. 568

• Polygenic Hypercholesterolemia• About 60 to 70% of a patient's cholesterol or LDL

level is genetically determined, with the remaining contribution from age, sex, diet, and other factors. The nature of these genetic effects is incompletely defined. Subjects in the upper range of the normal distribution have an increased CHD risk, and the upper 50% contribute about 80% of CHD cases.

Page 70: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton

2005 Conclusions

Page 71: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton

SUPERSIZE IT!

Page 72: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton
Page 73: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton
Page 74: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton
Page 75: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton

QuickTime™ and aTIFF (Uncompressed) decompressor

are needed to see this picture.

Page 76: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton

QuickTime™ and aTIFF (Uncompressed) decompressor

are needed to see this picture.

Page 77: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton

2005 Avant-garde or Profit ?

Experimental

??? Other types of

commercial

Tests available

for pay.

Stay tuned …

To be continued

Page 78: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton

Lipoprotein (Another view)

Page 79: Lipid Disorders MS2 Cardiovascular Lecture #62 November 7, 2006 Richard J. Baltaro, M.D., Ph.D., FCAP Associate Professor Department of Pathology Creighton

Questions?Questions?